Key Points

In Week 42 (October 12–18, 2026), compared with the previous week, the number of emergency department visits and hospitalizations following those visits increased among children under 2 years of age (+7%, or +1,590 visits and +220 hospitalizations) and remained stable in other age groups. Among those aged 15 and older, these figures were slightly higher than those of the previous 3 years.
Compared to the previous week, respiratory indicators were on the rise among children and those aged 75 and older. The levels observed were similar to or lower than in previous years.  

• Pneumonia among children (+17%, or +51 visits) and among those aged 75 and older (+5%, or
  +121 visits);
• Influenza/flu-like illness among children (+9%, or +27 visits) and among those aged 75 and older (+63%, or +55 visits);
• Suspected COVID-19 infection among those aged 75 and older (+17%, or +51 visits);
• Cough among adults (+13%, or +98 visits);
• ENT infections (+9%, or +447 visits) and asthma attacks (+15%, or +100 visits) in children under 2 years of age;
• Bronchiolitis in children under 1 year of age (+17%, or 142 visits).

There was also an increase in visits related to digestive conditions: acute gastroenteritis among children under 2 years of age (+7%, or 90 more visits) and among those aged 15–74 (+8%, or 99 more visits), vomiting among those aged 2–14 (+5%, or 47 more visits), and abdominal conditions among children under 2 years of age (+13%, or 78 more visits). Among those aged 75 and older, there was also an increase in visits for urinary tract infections (+6%, or +101 visits). 

Finally, among other indicators, there was an increase in visits for chest pain among those aged 15–74 (+7%, or +861 visits) and for cardiac decompensation among those aged 75 and older (+15%, or +193 visits).  Among children, there was an increase in visits for conjunctivitis (+16%, or 53 more visits), isolated fever among children under 2 years of age (+8%, or +152 visits), and among 2- to 14-year-olds for malaise (+21%, or +116 visits) and for neurological symptoms (+7%, or +64 visits).